MDM2 antagonists induce a paradoxical activation of Erk1/2 through a P53-dependent mechanism in dedifferentiated liposarcomas: implications for combinatorial strategies
Nom du journal : Cancers (Basel)
Année : 2020
Volume : 12
Page de départ : 2253